Pomalidomide has immunomodulatory and anti-tumour effects. It inhibits tumour cell proliferation, angiogenesis, and enhances immune response.
Recommended for:
Multiple myeloma in adults who have received at least two prior therapies including lenalidomide and bortezomib
Taken orally once daily, at the same time each day, with or without food. Must be used strictly as prescribed by the physician, usually in combination with dexamethasone.
Contraindications:
Side Effects:









